Comparison of Alectinib/Crizotinib Data in First-Line Therapy in Patients with Anaplastic Lymph omaki nase-Positive Nonsmall Cell Lung Carcinoma with Poor Prognostic Features for Alectinib.
| Autor: | Nuran Katgı1 nkatgi@hotmail.com, Çimen, Pınar1, Akyol, Murat2, Gürsoy, Pınar3, Agüloğlu, Nurşin4 |
|---|---|
| Zdroj: | Thoracic Research & Practice. Jul2023, Vol. 24 Issue 4, p180-185. 6p. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|